STOCK TITAN

Axcelis Technologies (ACLS) Stock Price, News & Analysis

ACLS NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
54 252 sessions, November 14, 2025 to November 16, 2026
Largest daily move
+22.4% close of May 6, 2026
1-year change
+21.7% closing prices, November 14, 2025 to November 16, 2026
1-month change
-8.4% closing prices, October 16, 2026 to November 16, 2026

Company Description

Axcelis Technologies Inc (Nasdaq: ACLS) operates in the semiconductor and related device manufacturing ecosystem as a supplier of ion implantation and other processing equipment used in the fabrication of semiconductor chips. According to company disclosures, Axcelis designs, manufactures and services ion implantation systems and provides lifecycle support for these tools, making ion implantation one of the most critical steps in integrated circuit (IC) manufacturing.

Axcelis is headquartered in Beverly, Massachusetts and has been providing ion implantation and related process solutions to the semiconductor industry for over 45 years. The company’s tools and services are used by chip manufacturers in multiple regions, with business presence in North America, Asia Pacific and Europe. A significant portion of revenue is derived from the Asia Pacific region, reflecting the concentration of global semiconductor fabrication capacity there.

Core business and product offering

The company’s core business centers on ion implantation systems and associated processing equipment for semiconductor device manufacturing. These systems are used to introduce dopants and modify material properties in wafers, enabling the performance characteristics required for a wide range of devices.

Axcelis also offers aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services and customer training. These offerings support the installed base of Axcelis systems at customer fabs and contribute recurring revenue tied to ongoing equipment utilization.

Recent company communications highlight several named platforms and product families within Axcelis’ ion implant portfolio:

  • Purion Power Series+™ – An ion implant product platform designed specifically to enable improved device performance and increased productivity for next generation power devices, including emerging superjunction architectures. The Purion Power Series+ spans the full ion implant market space with extensions such as Purion H200+ SiC for high current medium energy applications, Purion M+ SiC for medium current applications, and Purion XE+ SiC and Purion EXE+ SiC for high energy applications.
  • Purion H™ Series – A high current implant platform described as delivering purity and precision with high productivity across the high current operating space, using scanned spot beam technology with precise implant angle and dose control.
  • Purion XE™ Series – A high energy implant platform with a wide energy range, including the Purion XEmax model featuring Boost Technology™ for advanced sensor applications up to 15 MeV, based on company statements.
  • GSD Ovation™ ES – A high current ion implanter targeted for engineered substrates, providing high current hydrogen and helium implant capability for applications such as wafer splitting. Company materials describe it as an evolution of the GSD Ovation Series platform, which they characterize as a benchmark for batch implanter productivity.

Industry role and technology focus

Ion implantation is described by Axcelis as one of the most critical and enabling steps in IC manufacturing. The company positions its systems as enabling process applications that support device performance, yield and productivity. In recent announcements, Axcelis has emphasized solutions for power devices, including silicon carbide (SiC) power devices and superjunction architectures, as well as applications in sensor, memory and advanced logic markets.

Axcelis highlights technical capabilities in areas such as handling multiple wafer sizes (150mm and 200mm), supporting various substrate types including SiC, Si, GaN and GaAs, and operating across a range of implant temperatures from room temperature to warm and hot conditions. The company also notes beam power and wafer cooling capabilities for engineered substrates like SiC, LiTaO3 and LiNbO3 in its GSD Ovation ES system.

Geographic and market presence

Based on available information, Axcelis serves semiconductor manufacturers globally, with business presence in North America, Asia Pacific and Europe. Company statements reference a growing installed base and support infrastructure in Japan and long-standing relationships with Korean customers and partners, reflecting engagement with major semiconductor manufacturing regions.

The company participates in industry conferences and trade shows, such as SEMICON Japan and the International Conference on Silicon Carbide and Related Materials (ICSCRM), where it presents technical work on topics like high energy channeling implantation for SiC superjunction devices and related materials research in collaboration with device makers and research organizations.

Aftermarket and lifecycle support

In addition to new equipment sales, Axcelis provides aftermarket lifecycle products and services. These include used tools, spare parts, equipment upgrades, maintenance services and customer training, as described in company and third-party summaries. The company has reported record revenue from its customer service and installed base-related activities in recent financial communications, tying this performance to its aftermarket strategy and expansion of its installed base.

Corporate developments and combination with Veeco Instruments

Axcelis and Veeco Instruments Inc. have entered into an Agreement and Plan of Merger under which a wholly owned Axcelis subsidiary will merge with Veeco, with Veeco surviving as a wholly owned subsidiary of Axcelis. Under the agreement, each share of Veeco common stock will be converted into the right to receive Axcelis common stock at a specified exchange ratio, subject to the terms and conditions of the merger agreement.

Company disclosures state that the combined entity is expected to be a semiconductor equipment company serving complementary and diversified end markets, with an expanded product portfolio spanning ion implantation, laser annealing, ion beam deposition, advanced packaging solutions and metal organic chemical vapor deposition (MOCVD), supported by aftermarket services. The merger remains subject to shareholder approvals, regulatory clearances and other customary closing conditions, and the companies have indicated an expected closing timeframe in 2026, subject to these conditions.

The merger agreement also provides that, following closing, the combined company will have its headquarters in Beverly, Massachusetts and will assume a new corporate name, ticker symbol and brand to be mutually agreed by Axcelis and Veeco. Until the transaction closes, Axcelis common stock continues to trade under the ticker symbol ACLS on the Nasdaq Global Select Market.

Stock information and regulatory filings

Axcelis Technologies Inc common stock trades on Nasdaq under the symbol ACLS. As a U.S. public company, Axcelis files periodic and current reports with the Securities and Exchange Commission (SEC), including Forms 10-K, 10-Q and 8-K. Recent Form 8-K filings have covered quarterly financial results and the announcement and terms of the merger agreement with Veeco Instruments.

Stock Performance

$99.78
+0.56%
+0.56
Pre-marketLast updated: November 17, 2026 at 07:47
+21.7%
Performance 1 year

Axcelis Technologies (ACLS) closed at $99.22 on November 16, 2026. Over the past 12 months, the price has gained 21.7%.

See what a $1,000 investment in ACLS would be worth today

Average down calculator for ACLS

ACLS Metrics & Rankings

Price returns through November 16, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Financial Highlights

Axcelis Technologies generated $839.0M in revenue in FY2025, retaining a 44.9% gross margin, operating income reached $119.3M (14.2% operating margin), and net income was $120.2M, reflecting a 14.3% net profit margin. Diluted earnings per share stood at $3.80. The company generated $118.3M in operating cash flow. The current ratio was 4.77, measuring current assets divided by current liabilities.

$839.0M
Revenue (FY2025)
$120.2M
Net Income (FY2025)
$118.3M
Operating Cash Flow

Upcoming Events

NOV
30
November 30, 2026 - December 3, 2026 Marketing

UBS Tech & AI Conference

Axcelis to participate in UBS Global Technology & AI Conference at The Phoenician, Scottsdale, Nov 30–Dec 3, 2026; investor agenda available.
DEC
01
December 1, 2026 Marketing

Management Small Meetings

Axcelis management to host small group investor meetings at The Phoenician on Dec 1, 2026 during the UBS conference; contact IR for scheduling.
YEAR
2026
2026 Corporate

Annual sustainability report

Axcelis will report progress annually in its sustainability report; next report expected in 2026.
DEC
31
December 31, 2026 Financial

Q4 2026 quarter end

Quarter end for Q4 2026 (Dec 31, 2026). Axcelis expects ~ $275M revenue, GAAP EPS ~$1.15, non-GAAP EPS ~$1.50.
Q1
2027
Q1 2027 Corporate

ACLS VECO merger close

Expected closing of Axcelis–Veeco all-stock merger, subject to SAMR clearance and HSR re-filing; target by Q1 2027.
H2
2028
H2 2028 Operations

Production start

Production at Axcelis' new Pyeongtaek ion implantation facility scheduled in H2 2028 (window: 2028-07-01 to 2028-12-31).
YEAR
2030
2030 Regulatory

2030 emissions targets deadline

SBTi-approved targets: -65.88% scope 1&2 and -51.6% scope 3 (2022 base).
YEAR
2050
2050 Regulatory

2050 net-zero targets deadline

Commitment to net-zero by 2050: -90% scope 1&2 and -97% scope 3 (SBTi-approved).

Axcelis Technologies has 8 upcoming scheduled events. The next event, "UBS Tech & AI Conference", is scheduled for November 30, 2026 (in 13 days). 1 of them is a financing or capital event, such as a dividend or a debt maturity. Investors can track these dates to stay informed about potential catalysts that may affect the ACLS stock price.

Short Interest History

Last 12 Months

Short interest in Axcelis Technologies (ACLS) currently stands at 1.3 million shares, down 7.0% from the previous reporting period, representing 4.4% of the float. Since November 2025, short interest has decreased by 66.9%.

Days to Cover History

Last 12 Months

Days to cover for Axcelis Technologies (ACLS) currently stands at 4.1 days, down 12.5% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has decreased by 52.3%. Across the settlements charted above, it has ranged from 2.5 to 10.8 days.

ACLS Company Profile & Sector Positioning

Axcelis Technologies (ACLS) operates in the Semiconductor Equipment & Materials industry within the broader Technology sector and is listed on the NASDAQ.

Investors comparing ACLS often look at related companies in the same sector, including ACM Research, Inc. (ACMR), AXT Inc (AXTI), Veeco Instruments Inc (VECO), Kulicke & Soffa Industries Inc (KLIC), and IPG Photonics Corporation (IPGP). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ACLS's relative position within its industry.

Frequently Asked Questions

The current stock price of Axcelis Technologies (ACLS) is $99.78 in pre-market trading as of November 17, 2026.

The market cap of Axcelis Technologies (ACLS) is approximately $3.1B. Learn more about what market capitalization means .

The FY2025 revenue of Axcelis Technologies (ACLS) is $839.0M, from its most recent completed fiscal year.

The FY2025 net income of Axcelis Technologies (ACLS) is $120.2M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Axcelis Technologies (ACLS) is $3.80 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Axcelis Technologies (ACLS) is $118.3M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of Axcelis Technologies (ACLS) is 14.3% for FY2025, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of Axcelis Technologies (ACLS) is 14.2% for FY2025, its most recent completed fiscal year. Learn about operating margins.

The gross profit margin of Axcelis Technologies (ACLS) is 44.9% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Axcelis Technologies (ACLS), current assets divided by current liabilities, was 4.77 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Axcelis Technologies (ACLS) is $376.8M for FY2025, its most recent completed fiscal year.

The operating income of Axcelis Technologies (ACLS) is $119.3M for FY2025, its most recent completed fiscal year. Learn about operating income.